Cargando…

Assessment of a statistical AIF extraction method for dynamic PET studies with (15)O water and (18)F fluorodeoxyglucose in locally advanced breast cancer patients

Blood flow-metabolism mismatch from dynamic positron emission tomography (PET) studies with [Formula: see text]-labeled water ([Formula: see text]) and [Formula: see text]-labeled fluorodeoxyglucose (FDG) has been shown to be a promising diagnostic for locally advanced breast cancer (LABCa) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Sullivan, Finbarr, O’Sullivan, Janet N., Huang, Jian, Doot, Robert, Muzi, Mark, Schubert, Erin, Peterson, Lanell, Dunnwald, Lisa K., Mankoff, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Photo-Optical Instrumentation Engineers 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700771/
https://www.ncbi.nlm.nih.gov/pubmed/29201941
http://dx.doi.org/10.1117/1.JMI.5.1.011010
Descripción
Sumario:Blood flow-metabolism mismatch from dynamic positron emission tomography (PET) studies with [Formula: see text]-labeled water ([Formula: see text]) and [Formula: see text]-labeled fluorodeoxyglucose (FDG) has been shown to be a promising diagnostic for locally advanced breast cancer (LABCa) patients. The mismatch measurement involves kinetic analysis with the arterial blood time course (AIF) as an input function. We evaluate the use of a statistical method for AIF extraction (SAIF) in these studies. Fifty three LABCa patients had dynamic PET studies with [Formula: see text] and FDG. For each PET study, two AIFs were recovered, an SAIF extraction and also a manual extraction based on a region of interest placed over the left ventricle (LV-ROI). Blood flow-metabolism mismatch was obtained with each AIF, and kinetic and prognostic reliability comparisons were made. Strong correlations were found between kinetic assessments produced by both AIFs. SAIF AIFs retained the full prognostic value, for pathologic response and overall survival, of LV-ROI AIFs.